Showing results (51-60 of 107) with videos related to

Sort By:
Pageof 11
Clinical Epigenetics|May 12, 2017
Methylation of <i>DIRAS1</i> promotes colorectal cancer progression and may serve as a marker for poor prognosisRuipan Zheng, Dan Gao, Tao He, et al.
Cytokine|July 10, 2020
Combination of asprosin and adiponectin as a novel marker for diagnosing non-alcoholic fatty liver diseaseFan Ke, Guohui Xue, Xueling Jiang, et al.
International Journal of Clinical and Experimental Pathology|January 18, 2020
A primary myeloid sarcoma involving the small intestine and mesentery: case report and literature reviewTao He, Yun Guo, Chao Wang, et al.
Hepatitis Monthly|September 20, 2014
Effect of hepatitis B virus genotypes on the efficacy of adefovir dipivoxil antiviral therapyZhili Wen, Haiming Zhang, Meiying Zhang, et al.
Discovery Medicine|December 10, 2015
Methylation of RASSF10 promotes cell proliferation and serves as a docetaxel resistant marker in human breast cancerTenghui Dong, Meiying Zhang, Yan Dong, et al.
Plos One|November 7, 2014
Methylation of DACT2 promotes papillary thyroid cancer metastasis by activating Wnt signalingZhiyan Zhao, James G Herman, Malcolm V Brock, et al.
Oncotarget|July 1, 2015
Epigenetic silencing of NKD2, a major component of Wnt signaling, promotes breast cancer growthYan Dong, Baoping Cao, Meiying Zhang, et al.
Epigenomics|September 24, 2021
Methylation of <i>TMEM176A</i>, a key ERK signaling regulator, is a novel synthetic lethality marker of ATM inhibitors in human lung cancerHongxia Li, Weili Yang, Meiying Zhang, et al.
Oncogene|September 26, 2020
Aberrant NSUN2-mediated m<sup>5</sup>C modification of H19 lncRNA is associated with poor differentiation of hepatocellular carcinomaZhen Sun, Songlei Xue, Meiying Zhang, et al.
Nature Communications|January 17, 2018
Deubiquitinase USP13 dictates MCL1 stability and sensitivity to BH3 mimetic inhibitorsShengzhe Zhang, Meiying Zhang, Ying Jing, et al.
Pageof 11